• 1
    Simms RW. Fibromyalgia syndrome: current concepts in pathophysiology, clinical features, and management [review].Arthritis Care Res 1996;9:31528.
  • 2
    Hauser W, Zimmer C, Felde E, Kollner V. What are the key symptoms of fibromyalgia syndrome? Results of a survey of the German Fibromyalgia Association. Schmerz 2008;22:17683. In German.
  • 3
    Mease PJ, Dundon K, Sarzi-Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 2011;25:28597.
  • 4
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:16072.
  • 5
    Wolfe F, Clauw DJ, FitzCharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:60010.
  • 6
    Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27.
  • 7
    Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39:44853.
  • 8
    Buskila D, Neumann L, Odes LR, Schleifer E, Depsames R, Abu-Shakra M. The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Semin Arthritis Rheum 2001;30:4117.
  • 9
    Carmona L, Ballina J, Gabriel R, Laffon A, and the EPISER Study Group.The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001;60:10405.
  • 10
    White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:15706.
  • 11
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:1928.
  • 12
    Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 2013;65:77785.
  • 13
    Matsumoto M. Epidemiology of fibromyalgia. Pharma Medica 2006;24:359. In Japanese.
  • 14
    Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:72833.
  • 15
    Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, et al. Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 2011;14:7480.
  • 16
    Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T, et al. The Japanese version of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and the Fibromyalgia Symptom Scale: reliability and validity. Mod Rheumatol 2012;22:404.
  • 17
    White KP, Harth M, Speechley M, Ostbye T. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. J Rheumatol 1999;26:8804.
  • 18
    Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology project. Arthritis Care Res (Hoboken) 2012;65:76892.
  • 19
    Kamaleri Y, Natvig B, Ihlebaek CM, Bruusgaard D. Localized or widespread musculoskeletal pain: does it matter?Pain 2008;138:416.
  • 20
    Hattori S, Takeshima N, Kimura N, Kazushi Y, Akio M, Takayuki N. The clinical perspective on chronic pain management in Japan. Pain Clinic 2004;25:154151. In Japanese.
  • 21
    Matsudaira K, Takeshita K, Kunogi J, Yamazaki T, Hara N, Yamada K, et al. Prevalence and characteristics of chronic pain in the general Japanese population. Pain Clinic 2011;32:134556. In Japanese.
  • 22
    Wolfe F, Clauw DJ, FitzCharles MA, Goldenberg DL, Hauser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38:111322.
  • 23
    Hauser W, Jung E, Erbsloh-Moller B, Gesmann M, Kuhn-Becker H, Petermann F, et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One 2012;7:e37504.
  • 24
    Wolfe F, Hauser W, Hassett AL, Katz RS, Walitt BT. The development of fibromyalgia. I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 2011;152:2919.
  • 25
    Hauser W, Kosseva M, Uceyler N, Klose P, Sommer C. Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) 2011;63:80820.
  • 26
    Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 2010;10:102.
  • 27
    Hauser W, Schmutzer G, Glaesmer H, Brahler E. Prevalence and predictors of pain in several body regions: results of a representative German population survey. Schmerz 2009;23:46170. In German.